Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr Manash P Baruah

Dr Manash P Baruah

Consultant in Endocrinology, Apollo Excel Care Hospital, India

Dr Bennett Peter

Dr Bennett Peter

James Cook Hospital, UK

Prof. Andre Manov

Prof. Andre Manov

Mountain View Hospital, USA

Prof. Zhaoxia Liang

Prof. Zhaoxia Liang

Women’s Hospital, School of Medicine, Zhejiang University China

Endocrinology Conference 2024

Welcome Message

Welcome to the 20th World Congress on Endocrinology & Diabetes! For two decades, our congress has been a beacon of scientific discovery and collaboration, driving progress in endocrinology and diabetes care globally. This milestone event presents a comprehensive program showcasing the latest research, trends, and challenges in the field. We're excited to welcome experts and delegates from around the world, fostering diverse perspectives and interdisciplinary cooperation to improve patient outcomes.

For this special 20th edition, we have curated a comprehensive program that reflects the latest advancements, emerging trends, and pressing challenges in our field. From cutting-edge scientific symposia and keynote lectures by renowned thought leaders to interactive workshops and poster presentations showcasing novel findings, the congress offers a rich tapestry of educational opportunities for all attendees.

Moreover, we are delighted to host an international cohort of experts and delegates, representing a mosaic of perspectives, experiences, and expertise from across the globe. This diversity enriches our discussions, broadens our horizons, and fosters collaborations that transcend geographical boundaries, as we work together towards our shared goal of improving patient outcomes and enhancing quality of life for individuals affected by endocrine disorders and diabetes.

In closing, we extend our deepest gratitude to all our participants, speakers, sponsors, and partners for their invaluable contributions to the success of the 20th World Congress on Endocrinology & Diabetes. Together, let us seize this momentous opportunity to learn, connect, and inspire one another, as we continue our journey towards a healthier, more vibrant future for all.

About Conference

The 20th World Congress on Endocrinology & Diabetes, scheduled for November 22-23, 2024, in Amsterdam, Netherlands, is set to gather esteemed professionals and scholars from across the globe. This premier event promises an immersive experience filled with insightful discussions, cutting-edge discoveries, and valuable networking opportunities. Through a comprehensive program featuring keynote presentations, panel discussions, poster sessions, and workshops, attendees will explore a myriad of topics spanning hormone regulation, metabolic disorders, diabetes prevention and treatment, and emerging therapies in Endocrinology and diabetes.

THEME: Fostering Wellness: Integrative Approaches to Endocrine Health and Diabetes Management

Whether you're a seasoned researcher, clinician, educator, or industry expert, this congress offers a unique platform to exchange knowledge, foster collaboration, and strengthen connections within the global endocrinology and diabetes community. By convening in Amsterdam, we aim to propel the frontiers of endocrinology and diabetes care, driving positive transformations and enhancing patient outcomes worldwide. Join us at the Endocrinology Conference 2024 as we collectively shape the future of these critical disciplines.

Participation/Presentation Options

Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.

Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration.

Poster presentation: Student Poster Competition will be organized at the Endocrinology Conference 2024 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.

For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.

Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session.

E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.

Exhibition: Endocrinology Conference 2024 has the opportunity to exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?

Send your queries to

Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.

Send your proposal to to know the available advertisement options and prices

Sponsor Endocrinology Conference 2024

Premium Sponsorship package

Additional Sponsorship package

Mail the program manager at or WhatsApp on (+44 2045861247) to know more about the sponsorship packages.

Scientific Sessions and Tracks

Genetics and Epigenetics of Endocrine Diseases:

Understanding the genetic and epigenetic underpinnings of endocrine diseases is crucial for advancing diagnosis and treatment strategies. Genetic mutations can predispose individuals to conditions such as familial hypercholesterolemia or congenital adrenal hyperplasia. Meanwhile, epigenetic modifications, such as DNA methylation or histone acetylation, can influence gene expression patterns implicated in disorders like obesity or polycystic ovary syndrome. Exploring these molecular mechanisms sheds light on disease etiology and offers opportunities for targeted therapies and personalized medicine approaches.

Neuroendocrinology and Brain-Endocrine Interactions:

The intricate interplay between the brain and endocrine system governs essential physiological processes, including stress response, metabolism, and reproductive function. Neuroendocrine pathways involve hypothalamic-pituitary axes, where regulatory hormones like corticotropin-releasing hormone and gonadotropin-releasing hormone orchestrate hormonal secretion from peripheral glands. Dysregulation in these circuits can lead to disorders like Cushing's syndrome or hypogonadism. Investigating these interactions elucidates the neurobiological basis of endocrine diseases and informs novel therapeutic strategies targeting central mechanisms.

Pediatric Endocrinology and Growth Disorders:

Pediatric endocrinology encompasses the diagnosis and management of hormone-related conditions in children, with a particular focus on growth disorders such as short stature or precocious puberty. Hormonal imbalances during developmental stages can impact growth trajectories and overall health. Common pediatric endocrine conditions include congenital hypothyroidism, growth hormone deficiency, and diabetes mellitus type 1. Early detection and intervention are critical to optimizing growth and preventing long-term complications, emphasizing the importance of specialized care in pediatric endocrinology.

Thyroid Disorders: From Bench to Bedside:

Thyroid disorders encompass a spectrum of conditions affecting thyroid function, ranging from hypothyroidism to hyperthyroidism and thyroid cancer. Research in this field spans benchtop investigations elucidating molecular mechanisms underlying thyroid hormone synthesis and action to bedside clinical trials evaluating novel therapies. Disorders such as Graves' disease or Hashimoto's thyroiditis pose significant challenges in diagnosis and management, requiring a multidisciplinary approach involving endocrinologists, surgeons, and oncologists. Advancements in understanding thyroid physiology and pathology drive innovation in diagnostic techniques and therapeutic interventions, ultimately improving patient outcomes.

Adrenal Disorders: From Adrenarche to Adrenopause:

The adrenal glands play a crucial role in hormone production, regulating stress response, metabolism, and electrolyte balance. Disorders affecting the adrenal glands range from congenital conditions like congenital adrenal hyperplasia to acquired diseases such as Cushing's syndrome or adrenal insufficiency. Adrenarche marks the maturation of the adrenal cortex, while adrenopause represents age-related changes in adrenal function. Understanding the complexities of adrenal physiology and pathology is essential for diagnosing and managing adrenal disorders across the lifespan, from infancy to old age.

Reproductive Endocrinology and Fertility Preservation:

Reproductive endocrinology focuses on the hormonal regulation of reproductive processes and fertility. Conditions such as polycystic ovary syndrome, endometriosis, or male hypogonadism can impair fertility through disruptions in hormone levels or reproductive anatomy. Fertility preservation techniques, including cryopreservation of gametes or embryos, offer options for individuals facing fertility-threatening treatments like chemotherapy or gonadotoxic therapies. Advancements in assisted reproductive technologies continue to expand possibilities for fertility enhancement, addressing the diverse needs of individuals and couples seeking to build families.

Metabolic Bone Diseases and Osteoporosis:

Metabolic bone diseases encompass a group of disorders characterized by abnormalities in bone metabolism, leading to decreased bone density and increased fracture risk. Osteoporosis, the most common metabolic bone disease, results from an imbalance between bone formation and resorption, often exacerbated by hormonal changes, nutritional deficiencies, or aging. Management strategies focus on optimizing bone health through lifestyle modifications, pharmacotherapy, and fracture prevention strategies. Research efforts aim to unravel the complex pathophysiology of bone diseases and develop targeted therapies to mitigate skeletal fragility and reduce the burden of osteoporotic fractures.

Pathophysiology of Diabetes Mellitus:

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Type 1 diabetes arises from autoimmune destruction of pancreatic beta cells, leading to insulin deficiency, while Type 2 diabetes typically involves insulin resistance and relative insulin deficiency. Other forms, such as gestational diabetes or monogenic diabetes, have distinct pathophysiologic mechanisms. Dysregulation of glucose metabolism contributes to microvascular and macrovascular complications, emphasizing the importance of glycemic control in preventing long-term complications. Investigating the underlying pathophysiology of diabetes informs therapeutic approaches targeting glucose homeostasis and associated metabolic pathways.

Diabetes Prevention and Lifestyle Interventions:

Preventing diabetes onset or delaying its progression is paramount in reducing the global burden of the disease. Lifestyle interventions focusing on healthy eating, regular physical activity, and weight management play a central role in diabetes prevention efforts. Structured lifestyle modification programs have demonstrated efficacy in reducing diabetes incidence and improving metabolic parameters in high-risk individuals. Public health initiatives promoting healthy behaviors and environmental changes further support diabetes prevention efforts on a population level. Understanding the behavioral and environmental determinants of diabetes risk informs targeted interventions aimed at fostering sustainable lifestyle changes and reducing disease incidence.

Insulin Resistance and Metabolic Syndrome:

Insulin resistance lies at the core of metabolic syndrome, a cluster of metabolic abnormalities including central obesity, dyslipidemia, hypertension, and impaired glucose metabolism. Insulin resistance disrupts cellular signaling pathways, leading to metabolic dysregulation and increased cardiovascular risk. Mechanisms linking insulin resistance to metabolic syndrome involve adipose tissue dysfunction, chronic low-grade inflammation, and mitochondrial dysfunction. Lifestyle interventions targeting insulin sensitivity through dietary modifications and exercise can mitigate metabolic syndrome components and reduce cardiovascular risk. Pharmacotherapeutic approaches also aim to improve insulin sensitivity and address individual components of metabolic syndrome, emphasizing personalized management strategies in high-risk individuals.

Type 1 Diabetes: Advances in Research and Management:

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, necessitating lifelong insulin therapy for glycemic control. Recent advances in type 1 diabetes research focus on elucidating the immunopathogenesis of the disease and developing immunomodulatory therapies aimed at halting or delaying beta cell destruction. Innovations in insulin delivery systems, such as closed-loop systems or beta cell replacement therapies, aim to improve glycemic control and enhance quality of life for individuals with type 1 diabetes. Patient-centered care models emphasize individualized management strategies tailored to lifestyle preferences and treatment goals, highlighting the importance of multidisciplinary diabetes care teams in optimizing outcomes for individuals with type 1 diabetes.

Type 2 Diabetes: From Diagnosis to Personalized Management:

Type 2 diabetes accounts for the majority of diabetes cases worldwide and is characterized by insulin resistance and relative insulin deficiency. Early detection and intervention are crucial to prevent or delay diabetes-related complications. Diagnosis involves assessing glycemic parameters and identifying underlying risk factors such as obesity, sedentary lifestyle, or family history of diabetes. Personalized management strategies encompass lifestyle modifications, pharmacotherapy, and, in some cases, bariatric surgery. Continuous glucose monitoring and digital health solutions offer tools for real-time glycemic monitoring and self-management support. Patient education and shared decision-making empower individuals with type 2 diabetes to actively participate in their care, fostering long-term adherence to treatment regimens and improving health outcomes.

Diabetes Complications: Prevention and Management:

Diabetes complications encompass a wide range of microvascular and macrovascular disorders resulting from chronic hyperglycemia and associated metabolic abnormalities. Microvascular complications include diabetic nephropathy, retinopathy, and neuropathy, while macrovascular complications comprise coronary artery disease, stroke, and peripheral vascular disease. Prevention strategies focus on optimizing glycemic control, blood pressure management, and lipid profiles to reduce the risk of complications. Multifactorial interventions addressing modifiable risk factors, such as smoking cessation and lifestyle modifications, are integral to comprehensive diabetes care. Early detection and timely intervention through regular screening and targeted therapies are essential for mitigating the impact of diabetes complications on morbidity and mortality.

Diabetes Technology:

Advancements in diabetes technology revolutionize disease management and empower individuals with diabetes to achieve better glycemic control and quality of life. Continuous glucose monitoring (CGM) systems provide real-time glucose data, enabling timely adjustments in insulin therapy and lifestyle behaviors. Insulin pump therapy offers precise insulin delivery and flexibility in insulin dosing, mimicking physiological insulin secretion patterns. Closed-loop systems integrate CGM with insulin delivery algorithms, automating insulin dosing and improving glycemic outcomes. Emerging technologies, such as implantable continuous glucose sensors or hybrid closed-loop systems, promise further enhancements in diabetes management, emphasizing the transformative potential of diabetes technology in personalized care.

Endocrine Surgery and Minimally Invasive Techniques:

Endocrine surgery encompasses surgical interventions targeting endocrine glands, including the thyroid, parathyroid, adrenal, and pituitary glands. Minimally invasive techniques, such as laparoscopic or robotic-assisted surgery, offer advantages in terms of reduced operative morbidity, shorter hospital stays, and faster recovery times compared to traditional open approaches. Surgical management of endocrine disorders requires meticulous preoperative evaluation, intraoperative precision, and postoperative surveillance to optimize outcomes and minimize complications. Collaboration between endocrinologists, surgeons, and allied healthcare professionals is essential for comprehensive care delivery and multidisciplinary management of endocrine surgical patients.

Pituitary Disorders: From Diagnosis to Management:

Pituitary disorders encompass a spectrum of conditions affecting the pituitary gland's structure and function, including pituitary adenomas, hypopituitarism, and hyperpituitarism. Diagnosis involves comprehensive endocrine evaluation, neuroimaging studies, and functional assessments to delineate hormonal abnormalities and identify underlying etiologies. Management strategies vary depending on the specific pituitary disorder and may include surgical resection, medical therapy, or radiation therapy. Optimal management requires a multidisciplinary approach involving endocrinologists, neurosurgeons, and radiation oncologists to address hormonal imbalances, alleviate mass effects, and preserve pituitary function, thereby improving clinical outcomes and quality of life for patients with pituitary disorders.

Endocrine Immunology and Autoimmune Disorders:

Endocrine immunology explores the intricate interplay between the immune system and endocrine organs, particularly in the context of autoimmune disorders such as type 1 diabetes, Hashimoto's thyroiditis, or Addison's disease. Dysregulation of immune responses leads to autoimmune destruction of hormone-producing cells or disruption of endocrine function, resulting in hormone deficiencies or excesses. Understanding the immunopathogenesis of endocrine autoimmune disorders informs diagnostic approaches and therapeutic interventions aimed at modulating immune responses, preserving endocrine function, and mitigating disease progression. Immunomodulatory therapies, including immunosuppressive agents or biologic agents targeting specific immune pathways, hold promise in halting or attenuating autoimmune-mediated damage to endocrine tissues, heralding new avenues for personalized management in endocrine immunology.

Endocrine Effects of Aging:

Aging is associated with alterations in endocrine function, including changes in hormone secretion, receptor sensitivity, and feedback mechanisms. Age-related hormonal changes impact various physiological processes, such as metabolism, bone turnover, and reproductive function. Declining levels of sex hormones, growth hormone, and thyroid hormones contribute to age-related changes in body composition, cognition, and energy metabolism. Moreover, aging is associated with an increased prevalence of endocrine disorders, such as osteoporosis, sarcopenia, and hypogonadism. Understanding the endocrine effects of aging informs strategies for healthy aging, emphasizing the importance of hormonal balance, lifestyle modifications, and preventive healthcare measures to optimize endocrine health and overall well-being in older adults.

Endocrine Health in LGBTQ+ Populations:

Endocrine health in LGBTQ+ populations encompasses the unique healthcare needs and disparities faced by individuals who identify as lesbian, gay, bisexual, transgender, queer, or other sexual and gender minorities. Hormonal transitions associated with gender-affirming care, including hormone therapy and surgical interventions, require specialized management tailored to individual preferences and goals. Access to affirming and culturally competent healthcare services is essential for addressing hormone-related concerns and promoting endocrine health in LGBTQ+ communities. Moreover, awareness of the impact of societal stigma, discrimination, and minority stress on endocrine health underscores the importance of holistic approaches to care that address social determinants of health and promote health equity for LGBTQ+ individuals.

Translational Research in Endocrinology:

Translational research in endocrinology bridges the gap between basic science discoveries and clinical applications, translating scientific insights into novel diagnostic tools, therapeutic interventions, and healthcare practices. Integrating multidisciplinary approaches and collaborative networks facilitates the translation of laboratory findings into clinical trials and real-world clinical settings. Translational research efforts encompass a wide range of disciplines, including genetics, molecular biology, pharmacology, and epidemiology, with the aim of advancing our understanding of endocrine diseases and improving patient outcomes. Translational approaches facilitate the development of precision medicine strategies tailored to individual patients' genetic profiles, disease characteristics, and treatment responses, heralding a new era of personalized endocrine care.

Nutrition and Dietary Management in Diabetes:

Nutrition and dietary management are cornerstone components of diabetes care, influencing glycemic control, metabolic health, and overall well-being. Dietary interventions focus on optimizing macronutrient composition, portion sizes, and meal timing to regulate blood glucose levels and prevent postprandial hyperglycemia. Carbohydrate counting, glycemic index/load considerations, and personalized meal plans empower individuals with diabetes to make informed food choices and achieve glycemic targets. Nutrition education, counseling, and ongoing support are integral components of diabetes self-management, promoting dietary adherence and long-term metabolic control. Moreover, dietary strategies addressing cardiovascular risk factors, such as hypertension and dyslipidemia, contribute to comprehensive diabetes management and reduce the risk of cardiovascular complications.

Physical Activity and Exercise Prescription in Diabetes:

Physical activity and exercise play pivotal roles in diabetes management, improving insulin sensitivity, glucose uptake, and cardiovascular fitness. Exercise prescription involves tailoring exercise regimens to individual preferences, fitness levels, and medical considerations, aiming to achieve optimal glycemic control and overall health outcomes. Aerobic exercise, resistance training, and flexibility exercises each offer unique benefits for diabetes management, emphasizing the importance of incorporating diverse exercise modalities into routine physical activity routines. Multidisciplinary collaborations between healthcare providers, exercise physiologists, and certified diabetes educators facilitate personalized exercise prescriptions and ongoing support, empowering individuals with diabetes to adopt and maintain active lifestyles for long-term health and well-being.

Psychosocial Aspects of Diabetes Care:

Psychosocial factors significantly influence diabetes management and outcomes, encompassing psychological, social, and behavioral dimensions of health and illness. Diabetes distress, depression, anxiety, and social support networks impact self-care behaviors, medication adherence, and glycemic control. Culturally sensitive approaches to care address diverse psychosocial needs and preferences, fostering resilience and coping strategies to navigate the challenges of living with diabetes. Psychosocial interventions, such as cognitive-behavioral therapy, mindfulness-based stress reduction, and peer support programs, complement traditional medical treatments, promoting holistic diabetes care and improving quality of life for individuals with diabetes.

Diabetes Technology and Digital Health Solutions:

The integration of diabetes technology and digital health solutions revolutionizes diabetes management, empowering individuals with real-time data, decision support tools, and remote monitoring capabilities. Continuous glucose monitoring (CGM) systems provide insights into glucose trends and patterns, enabling proactive adjustments in insulin therapy and lifestyle behaviors. Insulin pumps deliver precise insulin doses and offer features such as automated insulin delivery algorithms and integration with CGM data. Diabetes management platforms and mobile applications facilitate data analysis, goal setting, and personalized feedback, enhancing self-management and engagement in care. Telemedicine and virtual care platforms expand access to specialized diabetes services, enabling remote consultations, education, and support for individuals with diabetes, particularly in underserved or rural communities.

Diabetes in Special Populations:

Diabetes presents unique challenges and considerations in special populations, including pregnant individuals, older adults, children, and individuals with comorbidities or disabilities. Gestational diabetes requires careful management to optimize maternal and fetal outcomes, emphasizing blood glucose monitoring, dietary modifications, and insulin therapy as needed. Diabetes in older adults necessitates tailored approaches to care, considering frailty, cognitive function, and polypharmacy concerns. Pediatric diabetes management involves age-appropriate education, family involvement, and psychosocial support to address developmental needs and promote self-management skills. Individuals with diabetes and comorbid conditions, such as cardiovascular disease or mental health disorders, benefit from multidisciplinary care coordination to address complex healthcare needs and optimize overall health outcomes.

Health Equity and Access to Diabetes Care:

Achieving health equity in diabetes care involves addressing disparities in access to healthcare services, resources, and outcomes among diverse populations. Socioeconomic factors, including income, education, insurance coverage, and geographic location, influence diabetes prevalence, management, and outcomes. Culturally competent care delivery considers diverse linguistic, cultural, and health literacy needs to ensure equitable access to diabetes education, prevention, and treatment services. Community-based interventions, advocacy efforts, and policy initiatives aim to reduce barriers to care and improve health outcomes for underserved and marginalized populations disproportionately affected by diabetes. Collaborative approaches involving stakeholders across healthcare, public health, and community organizations promote health equity and advance the goal of equitable diabetes care for all individuals.

Diabetes Education and Self-Management Support:

Diabetes education and self-management support are essential components of diabetes care, empowering individuals to take an active role in managing their condition and promoting optimal health outcomes. Diabetes self-management education and support (DSMES) programs provide comprehensive education on diabetes self-care behaviors, including blood glucose monitoring, medication management, healthy eating, physical activity, and coping skills. Tailored education and support services consider individual preferences, cultural background, and health literacy levels to promote adherence and behavior change. Peer support networks, group classes, and digital health platforms offer additional resources and social support for individuals with diabetes, fostering self-efficacy and empowerment in diabetes management.

Global Perspectives on Diabetes:

Diabetes is a global health challenge with significant social, economic, and health implications worldwide. Disparities in diabetes prevalence, access to care, and health outcomes exist across regions, countries, and populations, reflecting complex interactions between genetic, environmental, and socio-cultural factors. Multifaceted approaches to diabetes prevention and management encompass population-level interventions, policy initiatives, and healthcare system strengthening efforts to address the multifactorial determinants of diabetes. Collaborative partnerships between governments, non-governmental organizations, academia, and industry stakeholders facilitate knowledge sharing, capacity building, and innovation exchange to tackle the global burden of diabetes and promote sustainable solutions for diabetes prevention, treatment, and care.

Advancements in Diabetes Management:

Advancements in diabetes management encompass a wide range of innovations spanning clinical care, technology, research, and policy. Personalized medicine approaches leverage genetic insights, biomarkers, and digital health technologies to tailor diabetes treatment and prevention strategies to individual patient needs and characteristics. Novel therapeutic agents, including incretin-based therapies, SGLT-2 inhibitors, and GLP-1 receptor agonists, offer additional options for glycemic control and cardiovascular risk reduction. Precision nutrition, artificial intelligence, and telemedicine innovations enhance diabetes care delivery, patient engagement, and health outcomes. Furthermore, advances in diabetes research, including stem cell therapies, gene editing technologies, and immunomodulatory treatments, hold promise for future breakthroughs in diabetes prevention, cure, and management.

Endocrine Disorders in Pediatrics:

Endocrine disorders in pediatrics encompass a diverse array of conditions affecting hormonal regulation and growth in children and adolescents. Pediatric endocrinologists diagnose and manage disorders such as growth hormone deficiency, congenital adrenal hyperplasia, precocious puberty, and disorders of sexual development. Comprehensive care involves hormonal assessment, growth monitoring, and developmental evaluation to optimize outcomes and quality of life. Management strategies may include hormone replacement therapy, growth-promoting interventions, and multidisciplinary collaboration with specialists in genetics, urology, and psychology. Early detection and intervention are crucial to address endocrine disorders in pediatric patients and minimize long-term sequelae, highlighting the importance of specialized care and expertise in pediatric endocrinology.

Market Analysis

The Global Market for Endocrinology and Diabetes is characterized by a complex interplay of factors, including disease prevalence, technological advancements, and healthcare policies. The prevalence of diabetes and other endocrine disorders is on the rise worldwide, necessitating enhanced diagnostic and therapeutic solutions. With the number of adults living with diabetes projected to reach 700 million by 2045, there is a growing demand for innovative approaches to disease management and patient care.

Technological innovations have played a pivotal role in reshaping the landscape of endocrinology and diabetes care. Continuous glucose monitoring systems and advancements in insulin delivery devices have revolutionized disease management, enabling more precise control over blood glucose levels. Digital health technologies, such as telemedicine solutions and mobile health applications, have further expanded access to care, particularly in light of the COVID-19 pandemic. These developments not only improve patient outcomes but also empower individuals to take an active role in managing their health.

In parallel, there is a growing emphasis on personalized medicine approaches tailored to the individual needs and characteristics of patients. Pharmacogenomics and lifestyle interventions are increasingly being incorporated into treatment strategies, reflecting the recognition of the heterogeneity of these conditions. Additionally, the pharmaceutical industry is witnessing a wave of innovation in drug development, with novel therapeutics and next-generation insulin formulations expanding treatment options and improving patient outcomes. Moving forward, collaborative efforts among healthcare stakeholders will be crucial in addressing the challenges posed by endocrinology and diabetes and improving outcomes for patients worldwide.

To Collaborate Scientific Professionals around the World

Conference Date November 22-23, 2024

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Diabetes & Metabolism Journal of Nutrition & Food Sciences Journal of Endocrinology & Metabolic Syndrome Journal of Obesity & Weight Loss Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors




Media Partner


Media Partner


Media Partner


Media Partner


Media Partner




  • Acromegaly
  • Adrenal Cortex
  • Adrenal Disease
  • Adrenal Disorders
  • Adrenal Glands
  • Adrenal Health And Disease
  • Adrenaline
  • Adrenocorticotropin (ACTH
  • Amenorrhea
  • Androgens
  • Andropause
  • Angiotensin
  • Antiandrogens
  • Benign Prostatic Hyperplasia (Enlarged Prostate
  • Bioavailable Testosterone
  • Bioidentical Hormones
  • Bone And Mineral Disorders
  • Bone Health And Osteoporosis
  • Bone Mineral Density
  • Calcitonin
  • Calcium Phosphate Magnesium
  • Carcinoid Tumors
  • Cardiovascular Endocrinology
  • Cardiovascular Risk Reduction
  • Cholescystokinin
  • Cholesterol
  • Chronic Kidney Disease
  • Congenital Adrenal Hyperplasia
  • Cortisol
  • Cushing Syndrome
  • Dehydroepiandrosterone
  • Diabetes
  • Diabetes Algorithm
  • Diabetes And Glucose Metabolism
  • Diabetes Management
  • Diabetes Mellitus
  • Diabetes Treatment
  • Diabetic Microvascular Complications
  • Dihydrotestosteronemdash
  • Disorders Of Bone
  • Endocrine Myopathies
  • Endocrine Neoplasia And Cancer
  • Endocrine Tumors
  • Endocrine-Disrupting Chemicals
  • Erectile Dysfunction
  • Erectile Dysfunction (ED)
  • Erythropoietin
  • Estradiol
  • Estrogen
  • Estrogen Therapy
  • Estrone
  • Female Reproductive Endocrinology
  • Fluid And Electrolytes
  • Follicle Stimulating Hormone (FSH
  • Free Testosterone
  • Gastrin
  • Genomic Medicine
  • Ghrelin
  • Glands
  • Glucagon
  • Glucagon-Like Peptide
  • Glucose Intolerance
  • Goiter
  • Gonads
  • Graves Disease
  • Graves' Disease
  • Growth Hormone
  • Gynecomastia
  • Hard-to-spot Symptoms
  • Hirsutism
  • Hormone Physiology
  • Hormone Therapy
  • Hormones
  • Hot Flashes
  • Human Chorionic Gonadotropin Hormone
  • Hypercalcemia
  • Hypertension
  • Hypoglycemia
  • Hypogonadism
  • Hypothalamic, Pituitary, And Adrenal Disorders
  • Hypothalamus
  • Hypothyroidism
  • IGF-1
  • Insulin
  • Interactive Diabetes Cases
  • Kallmann Syndrome
  • Kisspeptin
  • Klinefelter Syndrome
  • Leptin
  • Lipid Disorders
  • Lipid Or Cholesterol Abnormalities
  • Lipids And Cardiovascular Risk Management
  • Luteinizing Hormone
  • Male Reproductive Endocrinology
  • Melatonin
  • Menopause
  • Metabolic Syndrome
  • Neuroendocrinology And Pituitary
  • Norepinephrine
  • Nutrition
  • Obesity
  • Obesity And Appetite Regulation
  • Obesity And Weight Management
  • Osteoporosis
  • Ovaries
  • Oxytocin
  • Pancreas
  • Parathyroid
  • Parathyroid Hormone
  • Patient Education
  • Pediatric Endocrinology
  • Peptide
  • Perimenopause
  • Pineal Gland
  • Pituitary Disease
  • Pituitary Gland
  • Polycystic Ovarian Syndrome
  • Polycystic Ovary Syndrome
  • Prader-Willi Syndrom
  • Pre-diabetes
  • Premenstrual Syndrome
  • Progesterone
  • Progestin
  • Prolactin
  • Prostaglandins
  • Relaxi
  • Reproductive Endocrine Female
  • Reproductive Endocrine Male
  • Reproductive Endocrinology
  • Residents
  • Serotonin&mdashSerotonin
  • Society Guidelines In Endocrinology And Diabetes
  • Somatostatin?Somatostatin
  • Steroids
  • Testes
  • Testosterone
  • Thymus
  • Thyroid Disease
  • Thyroid Disorders And Cancer
  • Thyroid-stimulating Hormone
  • Thyroxine
  • Total Testosterone
  • Transgender Medicine And Research
  • Turner Syndrome
  • Vitamin D
  • What's New In Endocrinology And Diabetes Mellitus